1067 Budapest, Eötvös utca 38, Hungary.
The price does not include VAT

PBSerum HA 2.0 LOW

SKU:

    PBSerum HA 2.0 LOW is a range of products developed by the Spanish laboratory Proteos Biotech, employing cutting-edge technology utilizing recombinant enzymes. These products combine high molecular weight hyaluronic acid with a carefully balanced enzyme cocktail. This formulation proves highly effective in addressing concerns such as scars, stretch marks, cellulite, and the reduction of fat deposits. Proteos Biotech ensures the highest safety standards in their biotechnology laboratories, adhering to ISO 13485 regulations throughout the development and production processes.

    The package includes:

    • 1st PBSerum HA 2.0
      PBSerum HA2.0 is a hyaluronic acid with a high molecular weight of 8 mg/ml and slightly cross-linked. It has anti-inflammatory, regenerative properties and stimulates the reorganization of collagen fibers in damaged tissues. Thanks to its characteristics, it is ideal for inhibiting, combating and preventing the appearance of fibrosis, which is the basis of our treatment. PBSerum HA2.0 is compatible with the use of enzymatic reagents of different intensity.
    • 2. Enzyme reagent with moderate action “MEDIUM”
      It helps to reduce excess body fat accompanying fibrosis. It stimulates lipid metabolism and triglyceride degradation to reduce the volume of adipocytes in areas with excessive accumulated fat. Contains active substances: Col G / H collagenase PB220, Lipase PB500, LYA Lyase PB72K

    Ingredients of the product:

    • Hyaluronic acid with a high molecular weight of 8 mg/ml and slightly cross-linked
    • Col G / H collagenase PB220
    • Lipase PB500
    • LYA Lyase PB72K

    The advantages of utilizing of PBSerum HA 2.0 LOW:

    • The use of biotechnological methods involving microorganisms enables the production of enzymes with a pure and uncomplicated structure, ensuring both effectiveness and hypoallergenic qualities.
    • Freeze drying, a preservation technique involving rapid freezing of the product, plays a pivotal role. This process maintains the stability of the products; the enzymes retain their complete properties and remain active without the need for added preservatives. Production is conducted in a class A cleanroom, ensuring product sterility. The advantages of freeze-drying include the products’ ability to be stored at temperatures between 1-30°C, eliminating the need for low-temperature storage.
    • In vitro and in vivo testing has demonstrated the efficacy of PBSerum MEDICAL enzymes. Results from in vivo trials indicate the products are well-suited for fibrosis treatment, with noticeable effects after the initial application. These outcomes are attributed to the properties of recombinant enzymes and their sterile preservation through freeze-drying, ensuring a high level of safety.

    Product Application Guidelines:

    Recommended Number of Treatments: 1-4

    Initial Visible Results: approximately 8-10 days after the procedure.

    Re-treatment: within 8-10 days